Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 08, 2025 03:00 ET | Source: Ultragenyx Pharmaceutical Inc.

Ultragenyx annuncia l'approvazione da parte dell'AIFA (Agenzia Italiana del Farmaco) del rimborso di Evkeeza® (evinacumab) per i pazienti pediatrici di età pari a 6 mesi con ipercolesterolemia familiare omozigote (HoFH)

MILANO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), azienda biofarmaceutica focalizzata sullo sviluppo e la commercializzazione di nuove terapie per malattie...
October 07, 2025 10:38 ET | Source: LEDVANCE GmbH

LEDVANCE Earns Triple Win in 2025 IES Progress Report for Lighting Innovations

WILMINGTON, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- LEDVANCE is proud to announce that three of its most innovative lighting solutions have won recognition in the 2025 Illuminating Engineering...
October 06, 2025 10:00 ET | Source: UltiSat, Inc.

UltiSat Awarded DOI-BLM Contract to Deliver Fire Mobile Satellite Internet for Wildland Firefighters

LAUREL, Md., Oct. 06, 2025 (GLOBE NEWSWIRE) -- UltiSat, an authorized government reseller of Starlink for Low Earth Orbit (LEO) satellite communication (SATCOM) solutions to the U.S. Government, is...
October 06, 2025 08:00 ET | Source: Axalta Coating Systems LLC

Axalta Unveils Innovative Coatings to Support Improved Battery Safety in Electric Vehicles

PHILADELPHIA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE: AXTA), a leading global coatings company, today will unveil two innovative products at The Battery Show North...
October 06, 2025 08:00 ET | Source: Hipp Health

Hipp Health Raises $6.2 Million in Seed Funding

Hipp Health, an AI platform that streamlines admin and compliance for behavioral practices, has raised a $6.2 million seed round led by RTP Global.
October 03, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc.

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NOVATO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
October 02, 2025 09:00 ET | Source: Ultrack Systems, Inc.

Ultrack Systems Inc. (OTC: MJLB) Subsidiary Better Pets Launches First Health Canada–Approved Product, Kicking Off Rebranded Pet Wellness Line

Ultrack Systems Inc. (OTC: MJLB) Subsidiary Better Pets Launches First Health Canada–Approved Product, Kicking Off Rebranded Pet Wellness Line
October 02, 2025 07:00 ET | Source: Q2 Metals Corp

Q2 Metals Appoints Simon Gaivin as Vice President - ESG, Cisco Lithium Project Named as Finalist for Discovery of the Year by AEMQ

Q2 Metals Appoints Simon Gaivin as Vice President - ESG, Cisco Lithium Project Named as Finalist for Discovery of the Year by AEMQ
September 30, 2025 16:05 ET | Source: Ultragenyx Pharmaceutical Inc.

Ultragenyx Appoints Eric Olson as Chief Business Officer and Executive Vice President

NOVATO, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced the appointment of Eric Olson as chief business officer (CBO) and executive vice...
September 30, 2025 06:00 ET | Source: Greenwich LifeSciences, Inc.

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial

STAFFORD, Texas, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...